Fundamentals screen · refreshed after the Sep 28, 2026 close
Fastest revenue growth: Healthcare
Larger companies growing quarterly revenue the fastest year over year. Latest quarter's revenue compared with the same quarter a year earlier.
| # | Company | Price | Revenue YoY | Quarterly revenue | Gross margin | Mkt cap |
|---|---|---|---|---|---|---|
| 1 | VIRVir BiotechnologyHealthcare | $10.51 | +19582.5% | $238.9M | 100.0% | $1.78B |
| 2 | MGTXMeiraGTx HoldingsHealthcare | $11.11 | +8608.6% | $321.4M | 97.8% | $1.07B |
| 3 | PGENPrecigenHealthcare | $7.81 | +6322.7% | $55.0M | 94.9% | $2.80B |
| 4 | PTGXProtagonist TherapeuticsHealthcare | $142.44 | +3749.2% | $213.5M | 100.0% | $9.22B |
| 5 | LQDALiquidiaHealthcare | $73.67 | +1842.7% | $171.7M | 93.3% | $6.59B |
| 6 | KYMRKymera TherapeuticsHealthcare | $112.00 | +466.4% | $65.0M | 100.0% | $9.31B |
| 7 | INSMInsmedHealthcare | $117.67 | +296.1% | $425.5M | 84.2% | $25.70B |
| 8 | URGNUroGen PharmaHealthcare | $40.90 | +199.2% | $72.5M | 90.9% | $2.00B |
| 9 | ARWRArrowhead ResearchHealthcare | $65.46 | +171.0% | $75.3M | 100.0% | $9.25B |
| 10 | SNDASonida Senior LivingHealthcare | $37.61 | +122.0% | $207.6M | 100.0% | $1.81B |
| 11 | BBIOBridgeBio PharmaHealthcare | $66.61 | +120.4% | $243.7M | 93.8% | $13.02B |
| 12 | WATWatersHealthcare | $442.94 | +113.4% | $1.65B | 44.6% | $43.52B |
| 13 | STAAStaar Surgical CoHealthcare | $20.87 | +111.0% | $93.5M | 74.5% | $1.05B |
| 14 | PTCTPTC TherapeuticsHealthcare | $65.95 | +101.5% | $360.5M | 94.5% | $5.50B |
| 15 | IBRXImmunityBioHealthcare | $8.52 | +93.9% | $51.2M | 99.4% | $9.03B |
| 16 | SNDXSyndax PharmaceuticalsHealthcare | $17.86 | +91.8% | $72.8M | 95.6% | $1.59B |
| 17 | MDGLMadrigal PharmaceuticalsHealthcare | $517.04 | +71.2% | $364.3M | 100.0% | $11.95B |
| 18 | TGTXTG TherapeuticsHealthcare | $56.19 | +70.3% | $240.3M | 82.9% | $8.60B |
| 19 | TARSTarsus PharmaceuticalsHealthcare | $76.81 | +69.4% | $173.9M | 93.0% | $3.59B |
| 20 | ALNYAlnylam PharmaceuticalsHealthcare | $255.36 | +66.9% | $1.29B | 76.9% | $34.17B |
| 21 | IOVAIovance BiotherapeuticsHealthcare | $10.99 | +65.7% | $99.3M | 56.1% | $4.98B |
| 22 | CRONCronos Group Inc. Common ShareHealthcare | $3.41 | +59.5% | $70.6M | 65.8% | $1.26B |
| 23 | ARQTArcutis BiotherapeuticsHealthcare | $27.33 | +59.3% | $129.9M | 91.6% | $3.44B |
| 24 | KNSAKiniksa Pharmaceuticals InternationalHealthcare | $76.10 | +55.4% | $243.6M | 90.3% | $5.94B |
| 25 | CDNACareDxHealthcare | $64.60 | +52.2% | $131.9M | 73.5% | $3.34B |
| 26 | GKOSGlaukosHealthcare | $158.56 | +49.5% | $185.6M | 81.7% | $9.35B |
| 27 | TVTXTravere TherapeuticsHealthcare | $61.57 | +48.2% | $169.6M | 98.7% | $5.80B |
| 28 | HALOHalozyme TherapeuticsHealthcare | $112.89 | +47.7% | $481.0M | 83.5% | $12.81B |
| 29 | LLYEli Lilly &Healthcare | $1,184.78 | +47.7% | $22.97B | 85.8% | $1.06T |
| 30 | RYTMRhythm PharmaceuticalsHealthcare | $98.56 | +46.9% | $71.3M | 87.5% | $6.79B |
| 31 | AXSMAxsome TherapeuticsHealthcare | $193.89 | +45.5% | $218.4M | 93.8% | $10.16B |
| 32 | CAICaris Life SciencesHealthcare | $31.75 | +45.4% | $263.7M | 68.1% | $8.97B |
| 33 | GHGuardant HealthHealthcare | $177.33 | +44.3% | $335.0M | 65.4% | $23.80B |
| 34 | OMDAOmada HealthHealthcare | $19.39 | +43.1% | $87.8M | 72.6% | $1.19B |
| 35 | MNKDMannkindHealthcare | $3.35 | +42.9% | $109.4M | 73.0% | $1.08B |
| 36 | NBIXNeurocrine BiosciencesHealthcare | $140.44 | +39.5% | $959.0M | 97.6% | $14.28B |
| 37 | HIMSHims & Hers HealthHealthcare | $28.78 | +38.2% | $753.2M | 63.8% | $6.71B |
| 38 | MIRMMirum PharmaceuticalsHealthcare | $87.96 | +37.9% | $176.2M | 82.8% | $5.71B |
| 39 | NTRANateraHealthcare | $411.77 | +37.7% | $752.8M | 64.5% | $59.35B |
| 40 | PNTGThe Pennant GroupHealthcare | $40.90 | +35.8% | $298.0M | 18.6% | $1.43B |
| 41 | COHRCoherentHealthcare | $282.45 | +33.7% | $2.05B | 38.5% | $55.31B |
| 42 | LGNDLigand PharmaceuticalsHealthcare | $314.10 | +33.7% | $63.7M | 82.2% | $6.26B |
| 43 | BCRXBioCryst PharmaceuticalsHealthcare | $8.47 | +33.6% | $218.3M | 98.2% | $2.16B |
| 44 | SUPNSupernus PharmaceuticalsHealthcare | $44.60 | +32.4% | $219.1M | 84.6% | $2.60B |
| 45 | CDRECadre HoldingsHealthcare | $26.06 | +31.8% | $207.1M | 42.1% | $1.12B |
| 46 | CORTCorcept TherapeuticsHealthcare | $115.63 | +31.7% | $256.1M | 98.4% | $12.50B |
| 47 | ESTAEstablishment Labs HoldingsHealthcare | $65.34 | +31.7% | $67.5M | 70.6% | $1.95B |
| 48 | HRMYHarmony Biosciences HoldingsHealthcare | $40.01 | +30.3% | $261.3M | 75.8% | $2.33B |
| 49 | TFXTeleflex IncorporatedHealthcare | $127.38 | +28.9% | $570.3M | 58.2% | $5.40B |
| 50 | XERSXeris Biopharma HoldingsHealthcare | $9.83 | +28.7% | $92.1M | 86.4% | $1.79B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.